These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2450344)

  • 21. [Cerebral infarction as first manifestation of thrombocytopenia caused by pentosan polysulfate].
    Gironell A; Arboix A; Altés A; Martí-Vilalta JL
    Med Clin (Barc); 1997 Apr; 108(16):636. PubMed ID: 9303962
    [No Abstract]   [Full Text] [Related]  

  • 22. Pentosan polysulphate associated thrombocytopenia.
    Follea G; Hamandjian I; Trzeciak MC; Nedey C; Streichenberger R; Dechavanne M
    Thromb Res; 1986 May; 42(3):413-8. PubMed ID: 2424121
    [No Abstract]   [Full Text] [Related]  

  • 23. Heparin-induced thrombocytopenia and pentosan polysulfate: treatment with a low molecular weight heparin despite in vitro platelet aggregation.
    Vitoux JF; Roncato M; Hourdebaigt P; Aiach M; Fiessinger JN
    Thromb Haemost; 1986 Apr; 55(2):294-5. PubMed ID: 2424119
    [No Abstract]   [Full Text] [Related]  

  • 24. Pentosan induced cerebral sagittal sinus thrombosis: a variant of heparin induced thrombocytopenia.
    Rice L; Kennedy D; Veach A
    J Urol; 1998 Dec; 160(6 Pt 1):2148. PubMed ID: 9817346
    [No Abstract]   [Full Text] [Related]  

  • 25. Pentosan Polysulfate-Associated Macular Disease in Patients With Interstitial Cystitis.
    Lyons RJ; Ahmad S; Ansari S; Foote JE; Jain N
    Obstet Gynecol; 2020 May; 135(5):1091-1094. PubMed ID: 32282604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Massive bleeding on a bladder protectant: a case report of pentosan polysulfate sodium-induced coagulopathy.
    Gill S; Naiman SC; Jamal A; Vickars LM
    Arch Intern Med; 2002 Jul; 162(14):1644-5. PubMed ID: 12123410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pentosan polysulfate sodium for treatment of interstitial cystitis/bladder pain syndrome: insights from a randomized, double-blind, placebo controlled study.
    Nickel JC; Herschorn S; Whitmore KE; Forrest JB; Hu P; Friedman AJ; Baseman AS
    J Urol; 2015 Mar; 193(3):857-62. PubMed ID: 25245489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I trial of pentosan polysulfate.
    Swain SM; Parker B; Wellstein A; Lippman ME; Steakley C; DeLap R
    Invest New Drugs; 1995; 13(1):55-62. PubMed ID: 7499109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strength of Association between Pentosan Polysulfate and a Novel Maculopathy.
    Hanif AM; Shah R; Yan J; Varghese JS; Patel SA; Cribbs BE; O'Keefe G; Hendrick AM; Shantha JG; Hubbard GB; Patel PS; Rao P; Yeh S; Jain N
    Ophthalmology; 2019 Oct; 126(10):1464-1466. PubMed ID: 31004677
    [No Abstract]   [Full Text] [Related]  

  • 30. Progressive Maculopathy After Discontinuation of Pentosan Polysulfate Sodium.
    Huckfeldt RM; Vavvas DG
    Ophthalmic Surg Lasers Imaging Retina; 2019 Oct; 50(10):656-659. PubMed ID: 31671200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidural hematoma after epidural steroid injection: a possible association with use of pentosan polysulfate sodium.
    Siddiqui MN; Ranasinghe JS; Siddiqui S
    Anesthesiology; 2001 Nov; 95(5):1307. PubMed ID: 11685018
    [No Abstract]   [Full Text] [Related]  

  • 32. Spinal anesthesia in a patient receiving pentosan polysulfate sodium.
    Cambic CR; Higgins N
    Int J Obstet Anesth; 2009 Oct; 18(4):425-6. PubMed ID: 19733051
    [No Abstract]   [Full Text] [Related]  

  • 33. [Bandage as a drug carrier--successful treatment of superficial thrombophlebitis with pentosan polysulfate].
    Hadlich J; Klöcking HP; Linse R; Schunk W
    Dermatol Monatsschr; 1990; 176(4):233-4. PubMed ID: 1695878
    [No Abstract]   [Full Text] [Related]  

  • 34. [Biological study of the action of pentosan polysulfate in severe burn patients].
    Freyburger G; Vergnes C; Hourdille R; Boisseau MR; Sanchéz R; Cutillas M; Perro G
    Ann Chir; 1984 Apr; 38(3):247-52. PubMed ID: 6203465
    [No Abstract]   [Full Text] [Related]  

  • 35. Pentosan polysulfate maculopathy versus age-related macular degeneration: comparative assessment with multimodal imaging.
    Christiansen JS; Barnes AC; Berry DE; Jain N
    Can J Ophthalmol; 2022 Feb; 57(1):16-22. PubMed ID: 33722504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Large Subfoveal Vitelliform Lesions in a Case of Pentosan Polysulfate Maculopathy.
    Wannamaker KW; Sisk RA
    Ophthalmology; 2020 Dec; 127(12):1641. PubMed ID: 33222775
    [No Abstract]   [Full Text] [Related]  

  • 37. POTENTIAL NEW-ONSET CLINICALLY DETECTABLE PENTOSAN POLYSULFATE MACULOPATHY YEARS AFTER DRUG CESSATION.
    Barnett JM; Jain N
    Retin Cases Brief Rep; 2022 Nov; 16(6):724-726. PubMed ID: 33229920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase I study of pentosan polysulfate sodium in patients with advanced malignancies.
    Lush RM; Figg WD; Pluda JM; Bitton R; Headlee D; Kohler D; Reed E; Sartor O; Cooper MR
    Ann Oncol; 1996 Nov; 7(9):939-44. PubMed ID: 9006745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel Multimethod Image Analysis to Quantify Pentosan Polysulfate Sodium Retinal Toxicity.
    Hadad A; Helmy O; Leeman S; Schaal S
    Ophthalmology; 2020 Mar; 127(3):429-431. PubMed ID: 31757495
    [No Abstract]   [Full Text] [Related]  

  • 40. Microperimetry Findings in Pentosan Polysulfate Maculopathy.
    Most J; Kalaw FGP; Walker E; Arias JD; Charng J; Baxter SL; Nudleman E; Ferreyra H; Freeman WR; Chen FK; Borooah S
    Ophthalmol Retina; 2023 Nov; 7(11):1022-1024. PubMed ID: 37619623
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.